CD8A and neoplasm: The frequency of tumor antigen (OVA protein-originated SIINFEKL peptide) specific T cell receptor (TCR)-expressing CD8+ T cells was significantly increased in the tumor microenvironment (TME) of HK-C60 administered mice compared with controls (Figure 2A).